Kenneth Kelley
Chief Executive Officer presso IDBiologics, Inc.
Profilo
Kenneth J. Kelley è un uomo d'affari che ha fondato IntraBiotics Pharmaceuticals, Inc. e Emergent Travel Health, Inc. e che è stato a capo di 7 diverse aziende. Attualmente ricopre la posizione di presidente di Seromyx Systems, Inc. e di presidente di Selva Therapeutics, Inc. Kelley fa anche parte del consiglio di amministrazione di Halozyme Therapeutics, Inc. (ex presidente), Meissa Vaccines, Inc., Actym Therapeutics, Inc. e IDBiologics, Inc. e amministratore delegato di K2 BioVentures LLC. Nella sua carriera passata Kenneth J. Kelley è stato direttore di Solus Biosystems, Inc., presidente di Fluxion Biosciences, Inc., socio generale di Latterell Venture Partners, socio di Institutional Venture Partners, consulente di McKinsey & Co., Inc., presidente e amministratore delegato di IntraBiotics Pharmaceuticals, Inc., direttore di Emergent Travel Health, Inc. e scienziato di Integrated Genetics, Inc. Kenneth J. Kelley si è laureato alla Harvard University e ha conseguito un MBA alla Stanford University.
Posizioni attive di Kenneth Kelley
| Società | Posizione | Inizio |
|---|---|---|
| K2 BioVentures LLC | Corporate Officer/Principal | 07/07/2010 |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Director/Board Member | 27/03/2019 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA. | Director/Board Member | - |
IDBiologics, Inc.
 IDBiologics, Inc. BiotechnologyHealth Technology IDBiologics, Inc. engages in the development of human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases. The company was founded in 2017 and is headquartered in Nashville, TN. | Chief Executive Officer | 01/01/2017 |
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Seromyx Systems, Inc. provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics. The company was founded by Galit Alter in July 2019 and is headquartered in Cambridge, MA. | Chairman | - |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Selva Therapeutics, Inc. is a privately held biotechnology company that is dedicated to developing therapeutics for infectious diseases. The company is based in Del Mar, CA. The company's main focus is on rapidly developing SLV213 for COVID-19, which has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics was founded by Thomas E. Daley and Felix Wilhelm Frueh, and Thomas E. Daley has been the CEO since incorporation. | Chairman | - |
Precedenti posizioni note di Kenneth Kelley
| Società | Posizione | Fine |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chairman | 01/01/2015 |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners (Latterell Venture Partners) is a venture capital firm founded in 2001 by Pat Latterell. The firm is headquartered in San Ramon, California. | Corporate Officer/Principal | 01/06/2004 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Kenneth Kelley
| Harvard University | Undergraduate Degree |
| Stanford University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Aziende private | 16 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners (Latterell Venture Partners) is a venture capital firm founded in 2001 by Pat Latterell. The firm is headquartered in San Ramon, California. | Finance |
Solus Biosystems, Inc.
 Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Solus Biosystems, Inc. developed tools for measurement of changes in protein conformation. It provided a rapid analysis tool to study conformational and structural changes in proteins. The company was founded by William B. Archibald in 2001 and was headquartered in Palo Alto, CA. | Electronic Technology |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Fluxion Biosciences, Inc.
 Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Fluxion Biosciences, Inc. conducts clinical research for early cancer detection and patient monitoring. It offers live cell analysis, automated patch clamping, and circulating tumor cell analysis. The company was founded by Michelle Khine, Cristian Ionescu-Zanetti, and Michael Schwartz in 2006 and is headquartered in Alameda, CA. | Technology Services |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Commercial Services |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Part of Laboratory Corp. of America Holdings, Integrated Genetics, Inc. is a pharmaceutical preparations company. The private company is based in Framingham, MA. The company was founded by Robert J. Carpenter. | Health Technology |
| K2 BioVentures LLC | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Meissa Vaccines, Inc. operates as a pharmaceutical development company. It focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus. The company was founded by Marty Moore and Roderick Tang in 2014 and is headquartered in South San Francisco, CA. | Health Technology |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA. | Health Technology |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Seromyx Systems, Inc. provides insight into the immune function to discover and develop vaccines, immunotherapies, drugs, and diagnostics. The company was founded by Galit Alter in July 2019 and is headquartered in Cambridge, MA. | Health Technology |
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology IDBiologics, Inc. engages in the development of human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases. The company was founded in 2017 and is headquartered in Nashville, TN. | Health Technology |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Selva Therapeutics, Inc. is a privately held biotechnology company that is dedicated to developing therapeutics for infectious diseases. The company is based in Del Mar, CA. The company's main focus is on rapidly developing SLV213 for COVID-19, which has the potential to fight multiple life-threatening infectious diseases. Selva Therapeutics was founded by Thomas E. Daley and Felix Wilhelm Frueh, and Thomas E. Daley has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Kenneth Kelley
